Market Cap (In TWD)
878.5 Million
Revenue (In TWD)
264.72 Million
Net Income (In TWD)
49.74 Million
Avg. Volume
21.62 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 32.0-41.0
- PE
- -
- EPS
- -
- Beta Value
- 0.46
- ISIN
- TW0006662000
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- -
- Employee Count
- -
- Website
- https://www.biolasco.com.tw
- Ipo Date
- 2018-01-04
- Details
- BioLASCO Taiwan Co., Ltd. provides bio-materials and surgical services in Taiwan and internationally. It breeds and produces SPF laboratory rats and mice, including outbreed stocks, inbreed strains, and immune deficient models, as well as offers special animal model services. The company also provides endotoxin detection, animal heath diagnostic, and serological kits, as well as biological indicators. In addition, it offers IVC systems and ventilated houses equipment; professional and automated animal watering systems; transponders; chlorine dioxide gas generators; mouse and rat tail cuff blood pressure systems, analgesia equipment, and animal behavioral equipment; metabolism and behavior systems, and trackers; XPERT cabinet X-ray systems; automatic cleaning equipment; workstations; isolation chambers; and foggers. BioLASCO Taiwan Co., Ltd. was founded in 1990 and is based in Taipei, Taiwan.
More Stocks
-
ALECAlector, Inc.
ALEC
-
USMT
-
6752
-
0IC9
-
WHGPF
-
0148
-
TNCAFTC Energy Corporation
TNCAF
-
603803RAISECOM TECHNOLOGY CO.,Ltd.
603803